Eribulin|cas 253128-41-5|supplier DC Chemicals

Cas No.:	253128-41-5
SMILES:	C=C1C[C@@](CC[C@@]2(C[C@@]3([H])O4)O[C@]([C@](O[C@](C5)([H])CC6)([H])[C@@]6([H])O7)([H])[C@@]4([H])[C@]7([H])[C@@]3([H])O2)([H])O[C@@]1([H])CC[C@](C[C@@H](C)C8=C)([H])O[C@]8([H])C[C@@](O[C@H](C[C@H](O)CN)[C@@H]9OC)([H])[C@]9([H])CC5=O
Formula:	C₄₀H₅₉NO₁₁
M.Wt:	729.9
Purity:	>99%
Sotrage:	2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Description:

For the detailed information of Eribulin, the solubility of Eribulin in water, the solubility of Eribulin in DMSO, the solubility of Eribulin in PBS buffer, the animal experiment（test） (test) of Eribulin, the cell expriment (test) of Eribulin, the in vivo, in vitro and clinical trial test of Eribulin, the EC50, IC50,and Affinity of Eribulin,, please contact DC Chemicals.

MSDS

COA

LOT NO.	DOWNLOAD

2018-0101

Cat. No.	Product name	Field of application
DCAPI1516	Eribulin	Eribulin Mesylate (E7389 Mesylate), a synthetic analogue of halichondrin B in phase III clinical trials for breast cancer, binds to tubulin and microtubules.